Siemens, Narrows

Siemens Narrows Its Focus as Record Orders Fuel an Upgraded Outlook

Published on 08/18/2026 at 14:41 | Redaktion boerse-global.de

Siemens lifts FY25/26 EPS outlook on record orders, advances Healthineers breakup with board changes and 2027 shareholder votes.

Siemens Raises Guidance, Moves to Separate Healthineers
Siemens Narrows Its Focus as Record Orders Fuel an Upgraded Outlook Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The machinery of corporate reinvention at Siemens is grinding audibly. The Munich-based industrial group has not only lifted its earnings guidance for fiscal 2025/26 off the back of a record quarter, but is also dismantling the supervisory board ties that bind it to its medical technology subsidiary, Siemens Healthineers — a clear signal that the long-mooted separation is moving from planning to execution.

At the heart of the operational story is an order book that keeps swelling. In the third fiscal quarter, incoming orders climbed 13% to €27.9 billion, with the Smart Infrastructure division the standout performer: order intake there surged 42%, powered by relentless demand for data-center infrastructure and grid technology. Group revenue rose 7% to €20.8 billion (8% on a comparable basis), while net income advanced 15% to €2.6 billion. Industrial profit jumped 25% to €3.5 billion, and free cash flow came in at a robust €4.1 billion.

That momentum has prompted management to raise its forecast for adjusted earnings per share to €11.20–€11.50, up from the previous range of €10.70–€11.10. The primary source had cited a slightly wider band of €11.20–€11.60, reflecting minor variations in how the guidance was framed. The Smart Infrastructure division also saw its comparable revenue growth outlook lifted to 10–11%, with an expected margin of 18.5–19.5%, while Digital Industries held its targets steady at 7–10% growth and a 17–19% margin.

Advertisement

As Siemens scales up its industrial operations, the same principle applies to your workplace: growth brings new risks that need documenting. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists helps you keep your safety documentation current and compliant as your business expands. Download the free Risk Assessment Toolkit

A Breakup Takes Shape

The corporate restructuring is proceeding on multiple fronts. Siemens currently holds roughly 67% of Healthineers and intends to reduce that stake to a pure financial holding over time, with an initial tranche of 30% slated for divestment. The separation is now legally crystallizing: tax matters with the authorities have been resolved, and shareholder votes at both companies are scheduled for the 2027 annual general meetings.

In a telling organizational move, CEO Roland Busch and CFO Veronika Bienert will relinquish their Healthineers supervisory board seats, effective at the medical firm's AGM in February 2027. The number of Siemens executive board members holding Healthineers mandates will shrink from three to one. The message is unambiguous: the parent is already loosening its grip before the formal split.

Healthineers itself has navigated a mixed quarter, trimming its full-year revenue growth forecast to 3.5–4.0% while raising its EPS guidance to €2.35–€2.45, helped by US tariff refunds.

Analysts Move Targets Higher

The strength of the order pipeline, particularly in data-center infrastructure, has not gone unnoticed on the sell side. Bernstein Research lifted its price target to €330 from €300 on August 13, reiterating an "Outperform" rating, while UBS analyst Andre Kukhnin had already raised his target to €330 from €310 on August 7 with a "Buy" recommendation, citing Smart Infrastructure's potential.

US Expansion and Internal Reshuffling

Beyond the Healthineers separation, Siemens is doubling down on its American footprint. The US subsidiary has announced a $185 million investment in a new factory in Georgia for low-voltage electrical components, a project expected to create around 1,400 jobs. Separately, more than $200 million is being channeled into two new US plants focused on data-center equipment — a bet squarely aimed at the artificial-intelligence boom.

At home, the company is also flattening its hierarchy. According to a Business Insider report, hundreds of managers are set to lose their C-level titles, a significant shift in the group's internal culture. Meanwhile, the share buyback program continues apace: between July 27 and August 2 alone, Siemens repurchased over 329,000 of its own shares, bringing the total since the new tranche began in early July to more than 1.47 million.

Advertisement

When companies restructure and expand into new facilities, fire safety obligations multiply — new buildings, new layouts, new evacuation routes. A free Fire Safety Toolkit gives you everything from risk assessments to evacuation plans and extinguisher training documents, so you can protect employees and premises as your operations grow. Get the free Fire Safety Toolkit

Market Position and Outlook

The stock closed Monday at €282.00, down 0.7% on the day, but remains just 3.2% below its 52-week high of €291.25 set in early August. Year-to-date, the shares have gained 18%, valuing the group at roughly €218 billion. A 30-day view shows a 7.3% advance.

A side note: a former software developer was sentenced to six months in a US court for planting a "logic bomb" in automated spreadsheets to fabricate system crashes and secure ongoing maintenance work. The case has no bearing on Siemens' operational trajectory.

The next full-year results are due November 12, when investors will be watching two things closely: whether Smart Infrastructure's order momentum can hold, and how swiftly the Healthineers stake reduction proceeds. The answers will determine whether this year's share-price run has further to go.

Disclaimer...

en | DE0007236101 | SIEMENS | boerse | 69964618 |